Dermadry
Dermadry is a Canadian medical device company that designs and sells FDA-cleared tap water iontophoresis devices for the at-home treatment of hyperhidrosis (excessive sweating) of the hands, feet, and underarms, sold direct-to-consumer globally across 100+ countries.
- Company typePrivate
- Founded2018
- HeadquartersMontréal, Canada
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Dermadry does
Dermadry Laboratories Inc. is a privately held Canadian medical device company headquartered in Montréal that designs, manufactures, and sells tap water iontophoresis devices for the at-home treatment of hyperhidrosis (excessive sweating) of the hands, feet, and underarms. The company's core product line consists of three devices — Dermadry Total, Dermadry Hands & Feet, and Dermadry Underarms — each delivering pulsed electrical current (1–15 mA for hands and feet, 1–8 mA for underarms) through water to temporarily disrupt sweat gland signaling. Notable technical components include aluminum-free graphite silicone electrodes, preset treatment profiles with polarity alternating sequences, and a safety pause function that prevents electric shock. The devices are assembled in Canada under ISO 13485:2016 MDSAP quality management procedures.
Dermadry operates a direct-to-consumer e-commerce model through dermadry.com, supplemented by Amazon marketplace listings and an authorized distributor in India (Jolly Technocrats). Pricing is structured as one-time device purchases ranging from $292.50 to $500, with recurring consumable revenue from replacement electrodes, underarm pockets, and silicone mats recommended for replacement every 30 sessions. Interest-free installment plans via Splitit (3–12 months) and HSA/FSA eligibility in the US reduce affordability friction. The primary customer segment is individuals aged 13+ (21+ in the US) with primary hyperhidrosis, supported by a secondary referral channel of dermatologists, podiatrists, and physicians.
The company has secured a multi-jurisdiction regulatory footprint, including Health Canada Medical Device Licence No. 101550 (2018), FDA 510(k) clearance K192749 (February 2020), CE marking via TÜV-SÜD, Australian Register of Therapeutic Goods registration, and ISO 13485 MDSAP certification. Distribution extends to more than 100 countries with free express shipping. Dermadry is founder-owned with no disclosed external institutional investment, no parent company, and no subsidiaries.
Dermadry firmographics
Firmographics- Name
- Dermadry
- Legal name
- Dermadry Laboratories Inc.
- Website
- https://dermadry.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dermadry is a Canadian medical device company that designs and sells FDA-cleared tap water iontophoresis devices for the at-home treatment of hyperhidrosis (excessive sweating) of the hands, feet, and underarms, sold direct-to-consumer globally across 100+ countries.
- Ownership category
- akta.pro rank
Where Dermadry is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Dermadry business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D
Revenue model
- Iontophoresis Device Sales: One-time purchase of medical devices (Dermadry Total, Hands & Feet, Underarms) providing long-term treatment solution. Prices range from $292.50-$500 with free express shipping worldwide.
- Consumables and Accessories: Replacement consumables including underarm pockets ($12.35-$19), silicone electrodes ($38.35-$51.35), silicone mats ($25.35-$39), and electrode bundles. Regular replacement recommended every 30 sessions.
- Payment Plan Financing: Interest-free installment payments through Splitit partnership, allowing customers to pay over 3-12 months. Revenue received upfront from Splitit.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Dermadry Total - Complete package for hands, feet & underarms |
| One time/ perpetual license | Pay-as-you-go | Dermadry Hands & Feet - For palmar and plantar hyperhidrosis |
| One time/ perpetual license | Pay-as-you-go | Dermadry Underarms - Targeted axillary treatment |
| One time/ perpetual license | Pay-as-you-go | Upgrade Kit - For existing Dermadry Total users |
| Unit Pricing | Pay-as-you-go | Consumables (pockets, electrodes, mats) |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Dermadry product offering
Product offeringCore offering
Dermadry manufactures and sells tap water iontophoresis medical devices for the at-home treatment of hyperhidrosis (excessive sweating) affecting hands, feet, and underarms. The company offers three core devices (Dermadry Total, Dermadry Hands & Feet, Dermadry Underarms) along with replacement consumables such as silicone-graphite electrodes, underarm pockets, and silicone mats. The devices use mild pulsed electrical current transmitted through tap water to temporarily halt sweat gland activity, providing drug-free, non-invasive relief lasting up to 6 weeks with maintenance.
Product overview
Dermadry offers a portfolio of iontophoresis medical devices for treating hyperhidrosis (excessive sweating). The core product line consists of three main devices: Dermadry Total (treats hands, feet, and underarms), Dermadry Hands & Feet (treats palmar and plantar hyperhidrosis), and Dermadry Underarms (treats axillary hyperhidrosis). The product portfolio also includes an Upgrade Kit with silicone-graphite electrodes and silicone mats for newer models, along with various consumables including underarm pockets, replacement electrodes, and silicone mats. The devices use tap water iontophoresis technology—a non-invasive, drug-free treatment that uses mild electrical current to temporarily block sweat gland production, providing results lasting up to 6 weeks with maintenance treatments.
Differentiator
Problem solved
Functional benefit
Products and services
- Dermadry Total Complete iontophoresis machine for treating hyperhidrosis affecting hands, feet, and underarms. FDA-cleared and Health Canada-licensed for palmar, plantar, and axillary hyperhidrosis, providing up to 6 weeks of dryness between maintenance treatments.
- Dermadry Hands & Feet Iontophoresis device designed for treating excessive sweating of the hands and feet (palmar and plantar hyperhidrosis). Includes treatment trays, electrodes, silicone mats, controller, and compact carrying case.
- Dermadry Underarms Iontophoresis machine specifically designed for treating excessive underarm sweating (axillary hyperhidrosis). Features 15-minute treatment sessions with 1-8 mA current strength.
- Dermadry Upgrade Kit Standalone upgrade kit for existing Dermadry Total device owners, providing aluminum-free and latex-free silicone-graphite electrodes, perforated silicone mats, and a compact carrying case to modernize older units.
- Set of Underarms Pockets Replacement underarm pockets made from absorbent material designed to absorb the right amount of water for comfortable iontophoresis treatment of axillary hyperhidrosis.
- Hands & Feet Silicone-Graphite Electrodes Replacement conductive graphite silicone electrodes providing an aluminum-free treatment option for hands and feet iontophoresis. Flexible, tear-resistant, corrosion-resistant, and durable construction.
- Underarm Silicone-Graphite Electrodes Replacement underarm silicone-graphite electrodes designed to embrace the underarm for safe and localized iontophoresis treatment. Aluminum-free construction suitable for users with aluminum sensitivities.
- Set of Silicone Mats Easy-to-clean silicone mats for protecting hands and feet during iontophoresis treatment. Waterproof and replace traditional cotton towels for quick post-treatment clean-up.
- Consumable Bundle - Underarms Complete underarm treatment bundle including underarm electrodes along with two sets of underarm pockets, designed for users of older Dermadry underarm devices.
Quantifiable outcome
- 98.3% of users experience reduction in sweat levels (749-person internal survey)
- +4 more outcomes
Companies that use Dermadry
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles2 records
Dermadry technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature5 records
Dermadry partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered regional, core and minor.
- Jolly TechnocratsregionalAuthorized distributor in India enabling customers to purchase Dermadry products locally. Addresses customs concerns that prevent direct international shipping to India. Contact via jollytechnocrats.in.
- SplititcorePayment plan provider enabling interest-free installments (3-12 months) for Dermadry purchases. No credit check, instant approval. Works with existing credit cards. Enables higher ticket purchases.
- International Hyperhidrosis SocietyminorNon-profit organization supporter. Dermadry featured on IHHS website as recommended treatment option. Supports hyperhidrosis awareness initiatives including Voices of Hyperhidrosis campaign.
- Board-Certified Dermatologists (Dr. Ramin Fathi, Dr. Raj Singh, Dr. Ryan De Cruz)minorMedical professionals who recommend Dermadry to patients and provide testimonials/endorsements. Quotes featured on website as trust signals for customer acquisition.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Dermadry competitors and assessment
Company assessmentDirect peers
- R.A. Fischer: Established US iontophoresis device manufacturer serving medical and physical therapy markets, including hyperhidrosis treatment. Closely comparable in product category, customer base (patients + clinicians), and regulated medical-device positioning.
- Hidrex: German manufacturer of iontophoresis devices for hyperhidrosis, with a long-standing presence in Europe and a US arm. Direct competitor in the same product modality (tap-water iontophoresis) targeting the same hyperhidrosis patient base.
- STD Pharmaceutical Products: UK-based company that historically supplied iontophoresis devices (Iontophor) and related dermatology products for hyperhidrosis. Direct competitor in iontophoresis modality with comparable DTC and clinical channels.
Emerging players
- Carpe: DTC antiperspirant brand specifically formulated for hyperhidrosis, with strong social-media presence and target-customer overlap. Competes for the same hyperhidrosis consumer dollar but via topical OTC rather than device-based treatment.
- Miramar Labs (miraDry): Developer of the miraDry system, a microwave-based in-office procedure for axillary hyperhidrosis. Comparable only in target condition (hyperhidrosis) but uses an entirely different treatment modality and delivery setting (clinical vs. at-home).
- Botanix Pharmaceuticals: Developer of sofpironium bromide (Sofdra), a topical prescription gel for primary axillary hyperhidrosis. Adjacent modality (topical) sharing the same target condition; potential direct competitor for at-home hyperhidrosis treatment.
Broad incumbents
- AbbVie (Botox): Owns Botox, an FDA-approved neurotoxin injection for severe primary axillary hyperhidrosis. Competes indirectly for the same patient population via a clinical in-office procedure, and frequently cited as Dermadry's main alternative-treatment option.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Dermadry social profiles
Digital presenceDermadry compliance and trust
Trust signalCompliance7 records
Dermadry financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dermadry leadership team
Management profileNumber of profiles
Dermadry funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dermadry M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dermadry
What does Dermadry do?
Dermadry manufactures and sells tap water iontophoresis medical devices for the at-home treatment of hyperhidrosis (excessive sweating) affecting hands, feet, and underarms. The company offers three core devices (Dermadry Total, Dermadry Hands & Feet, Dermadry Underarms) along with replacement consumables such as silicone-graphite electrodes, underarm pockets, and silicone mats. The devices use mild pulsed electrical current transmitted through tap water to temporarily halt sweat gland activity, providing drug-free, non-invasive relief lasting up to 6 weeks with maintenance.
Is Dermadry a public or private company?
Dermadry is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dermadry founded?
Dermadry was founded in 2018. It employs 11 to 50 people.
Where is Dermadry based?
Dermadry is headquartered in Montréal, Canada, in the North America region.
How does Dermadry make money?
Three revenue lines are on record. Iontophoresis Device Sales are the primary driver. The others are consumables and Accessories and payment Plan Financing.
Who are Dermadry's main competitors?
Direct peers on record are R.A. Fischer, Hidrex and STD Pharmaceutical Products. Emerging players are Carpe, Miramar Labs (miraDry) and Botanix Pharmaceuticals. AbbVie (Botox) is listed as a broad incumbent.
Does Dermadry have an API?
No public API is recorded for Dermadry.